Cargando…

Pioglitazone Protects Against Renal Ischemia-Reperfusion Injury via the AMP-Activated Protein Kinase-Regulated Autophagy Pathway

Renal ischemia-reperfusion injury (IRI) is a major cause of acute renal failure. Our previous studies have shown that pioglitazone, a peroxisome proliferators-activated receptor (PPAR)-γ agonist used in type 2 diabetes, protects against renal IRI; however, the molecular mechanism underlying the reno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Wenlin, Xi, Xiaoqing, Zhang, Shuangyang, Zou, Cong, Kuang, Renrui, Ye, Zhenfeng, Huang, Yawei, Hu, Honglin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6088275/ https://www.ncbi.nlm.nih.gov/pubmed/30127742 http://dx.doi.org/10.3389/fphar.2018.00851

Ejemplares similares

Pioglitazone Ameliorates Renal Ischemia-Reperfusion Injury via Inhibition of NF-κB Activation and Inflammation in Rats
por: Zou, Gaode, et al.
Publicado: (2021)

Pioglitazone Attenuates Reoxygenation Injury in Renal Tubular NRK-52E Cells Exposed to High Glucose via Inhibiting Oxidative Stress and Endoplasmic Reticulum Stress
por: Zou, Cong, et al.
Publicado: (2020)

Aliskiren Improves Ischemia- and Oxygen Glucose Deprivation-Induced Cardiac Injury through Activation of Autophagy and AMP-Activated Protein Kinase
por: Chiang, Ming-Hsien, et al.
Publicado: (2017)

PPARγ in Ischemia-Reperfusion Injury: Overview of the Biology and Therapy
por: Huang, Ruizhen, et al.
Publicado: (2021)

Activation of Nrf2 by Lithospermic Acid Ameliorates Myocardial Ischemia and Reperfusion Injury by Promoting Phosphorylation of AMP-Activated Protein Kinase α (AMPKα)
por: Zhang, Min, et al.
Publicado: (2021)

The Regulatory Role of Non-coding RNA in Autophagy in Myocardial Ischemia-Reperfusion Injury
por: Wang, Dan, et al.
Publicado: (2022)

Antithrombin III Alleviates Myocardial Ischemia/Reperfusion Injury by Inhibiting Excessive Autophagy in a Phosphoinositide 3-Kinase/Akt-Dependent Manner
por: Huang, Kai-yu, et al.
Publicado: (2019)

Gender Differential Expression of AR/miR-21 Signaling Axis and Its Protective Effect on Renal Ischemia-Reperfusion Injury
por: Huang, Gaomin, et al.
Publicado: (2022)

Riclinoctaose Attenuates Renal Ischemia-Reperfusion Injury by the Regulation of Macrophage Polarization
por: Zhao, Yang, et al.
Publicado: (2021)

SIK2 Improving Mitochondrial Autophagy Restriction Induced by Cerebral Ischemia-Reperfusion in Rats
por: Zhang, Ran, et al.
Publicado: (2022)

Fisetin Attenuates Myocardial Ischemia-Reperfusion Injury by Activating the Reperfusion Injury Salvage Kinase (RISK) Signaling Pathway
por: Shanmugam, Karthi, et al.
Publicado: (2021)

Paeonol Protects Against Myocardial Ischemia/Reperfusion-Induced Injury by Mediating Apoptosis and Autophagy Crosstalk
por: Tsai, Chin-Feng, et al.
Publicado: (2021)

Protective Role of AMP-Activated Protein Kinase-Evoked Autophagy on an In Vitro Model of Ischemia/Reperfusion-Induced Renal Tubular Cell Injury
por: Wang, Li-Ting, et al.
Publicado: (2013)

c-Jun N-Terminal Kinases (JNKs) in Myocardial and Cerebral Ischemia/Reperfusion Injury
por: Shvedova, Maria, et al.
Publicado: (2018)

Use of pioglitazone in the treatment of diabetes: effect on cardiovascular risk
por: Zou, Cong, et al.
Publicado: (2013)

QishenYiqi dripping pill protects against myocardial ischemia/reperfusion injury via suppressing excessive autophagy and NLRP3 inflammasome based on network pharmacology and experimental pharmacology
por: Li, Meng, et al.
Publicado: (2022)

Sanqi Oral Solution Ameliorates Renal Ischemia/Reperfusion Injury via Reducing Apoptosis and Enhancing Autophagy: Involvement of ERK/mTOR Pathways
por: Tian, Ruimin, et al.
Publicado: (2020)

Role of curcumin in ischemia and reperfusion injury
por: Bi, Minglei, et al.
Publicado: (2023)

Baicalein Attenuates Pyroptosis and Endoplasmic Reticulum Stress Following Spinal Cord Ischemia-Reperfusion Injury via Autophagy Enhancement
por: Wu, Chenyu, et al.
Publicado: (2020)

Farrerol Alleviates Myocardial Ischemia/Reperfusion Injury by Targeting Macrophages and NLRP3
por: Zhou, Lin, et al.
Publicado: (2022)

Current clinical evidence on pioglitazone pharmacogenomics
por: Kawaguchi-Suzuki, Marina, et al.
Publicado: (2013)

Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
por: Ye, Jingxue, et al.
Publicado: (2020)

Dexmedetomidine Protects Human Cardiomyocytes Against Ischemia-Reperfusion Injury Through α2-Adrenergic Receptor/AMPK-Dependent Autophagy
por: Xiao, Yingying, et al.
Publicado: (2021)

Ethoxysanguinarine, a Novel Direct Activator of AMP-Activated Protein Kinase, Induces Autophagy and Exhibits Therapeutic Potential in Breast Cancer Cells
por: Si, Yuan, et al.
Publicado: (2020)

Eugenol Attenuates Cerebral Ischemia-Reperfusion Injury by Enhancing Autophagy via AMPK-mTOR-P70S6K Pathway
por: Sun, Xiaowei, et al.
Publicado: (2020)

Corrigendum: Hydroxysafflor Yellow A Protects Against Myocardial Ischemia/Reperfusion Injury via Suppressing NLRP3 Inflammasome and Activating Autophagy
por: Ye, Jingxue, et al.
Publicado: (2021)

Protective Effects of HDL Against Ischemia/Reperfusion Injury
por: Gomaraschi, Monica, et al.
Publicado: (2016)

EGCG protects the mouse brain against cerebral ischemia/reperfusion injury by suppressing autophagy via the AKT/AMPK/mTOR phosphorylation pathway
por: Wang, Li, et al.
Publicado: (2022)

Norswertianolin Promotes Cystathionine γ-Lyase Activity and Attenuates Renal Ischemia/Reperfusion Injury and Hypertension
por: Niu, Yaping, et al.
Publicado: (2021)

CaMKII-dependent responses to ischemia and reperfusion challenges in the heart
por: Bell, James R., et al.
Publicado: (2014)

Somatostatin and Its Receptors in Myocardial Ischemia/Reperfusion Injury and Cardioprotection
por: Vörös, Imre, et al.
Publicado: (2021)

Mitochondrial DNA Release Contributes to Intestinal Ischemia/Reperfusion Injury
por: Liao, Shishi, et al.
Publicado: (2022)

Puerarin: A protective drug against ischemia-reperfusion injury
por: Gao, Minglang, et al.
Publicado: (2022)

Metabolomics profiling to characterize cerebral ischemia-reperfusion injury in mice
por: Chen, Qiong, et al.
Publicado: (2023)

Propofol Inhibits Ischemia/Reperfusion-Induced Cardiotoxicity Through the Protein Kinase C/Nuclear Factor Erythroid 2-Related Factor Pathway
por: Li, Shengqiang, et al.
Publicado: (2021)

Dexmedetomidine Attenuates Ferroptosis-Mediated Renal Ischemia/Reperfusion Injury and Inflammation by Inhibiting ACSL4 via α2-AR
por: Tao, Wen-hui, et al.
Publicado: (2022)

Inhibition of macrophage migration inhibitory factor (MIF) suppresses apoptosis signal-regulating kinase 1 to protect against liver ischemia/reperfusion injury
por: Chen, Sanyang, et al.
Publicado: (2022)

Deferoxamine Treatment Combined With Sevoflurane Postconditioning Attenuates Myocardial Ischemia-Reperfusion Injury by Restoring HIF-1/BNIP3-Mediated Mitochondrial Autophagy in GK Rats
por: Yang, Long, et al.
Publicado: (2020)

Chick Embryo: A Preclinical Model for Understanding Ischemia-Reperfusion Mechanism
por: Fauzia, Eram, et al.
Publicado: (2018)

Gerontoxanthone I and Macluraxanthone Induce Mitophagy and Attenuate Ischemia/Reperfusion Injury
por: Xiang, Qian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l53huv25eifa77ubrt93tnns3q